Impact of COVID-19 on Economy, Industry and Company :
The emergence of novel coronavirus has affected the global economy, industry dynamics and company’s top line. The entire ecosystem has to suffer the impact of this pandemic disease which would result in significant demand & supply gap, production delay and weak consumer demand of end products across industries. At Bizizz Market Research, our analyst has done extensive research across industries and identify various methodologies which would assist C-Level executive to counter this ongoing threat and make informed business decision.
Kindly contact us to know more details: https://www.bizizzmarketresearch.com/contact
The 3D Cell Culture System Market Is Estimated To Be US$ 822 Mn In 2019 And It Is Expected To Reach More Than US$ 3413 Mn By 2028, Likely To Grow With The CAGR Of 15.3 % During The Forecast Period.
In recent times many health care institutions, pharm companies, and research organizations have started adopting a 3D cell culture system to get effective and affordable treatments for cancers. This is a favorable growth trend for the global 3D cell culture system market. This technique is widely used in cancer research, tissue engineering, and stem cell research. Also, the 3D cell culture system has the ability to provide more physiologically relevant information and more predictive data for in-vivo tests. Such advantages offered by the 3D cell culture system make it useful in a wide range of applications such as disease pathology, drug discovery and organ transplantation. The study of the functions, proliferation, and differentiation of a cell has remarkably increased the usage of the 3D cell culture system.
3D cell culture system offers an ideal environment for the assessment of diseases at various stages with the help of cellular modeling. As 2D cell culture has faced certain limitations during this process, the 3D cell culture technique provides an artificially created environment where cells interact with their surroundings in three-dimensions.
Rising Global R&D Investments In Cell-Based Research Will Drive The 3D Cell Culture System Market
In 2019, the total worldwide R&D spend of pharmaceutical and biotechnology companies amounts to USD 150 billion, the global average R&D rate (R&D as per cent of sales) of pharma and biotech companies is 10.6 % (for the big players up to 20 %)2017. While In 2028, it is projecting that the top 20 companies will be spending USD 116.4 billion on R&D, 16.9% of sales still a very high percentage when compared to other industries. The rise investments in R&D will drive the 3D cell culture system market.
Along with the rising investments in R&D, the rise in need for organ transplantation have boost use of 3D cell culture system models as an alternative tool for in vivo testing and increasing focus on regenerative medicine are key factors propelling the growth of the market.
However, the expenses of the system and technologies associated with the 3D cell culture system and the lack of experienced and skilled professionals will hamper the market growth to the some extent in short term.
Biotech And Pharma Companies Dominated The 3D Cell Culture System Market With Over 47.0% Revenue Share In 2019 In The End-User Segment.
An increase in R&D spending with a large number of pharmaceutical & biotechnology companies will boost the 3D cell culture system market. Also, the growing preference for alternative testing models over animal techniques are the key market drivers in this end-user segment.
The stem cell research application is forecasted to have the highest CAGR of 12.3%.
Many researchers have contributed to clinical trials of stem cell approaches to treating colorectal cancer, spinal cord injury, vision problems, and Alzheimer’s disease. Researchers have also used stem cells to uncover essential insights about, ALS, arthritis, kidney disease, Zika virus, congenital disabilities and a wide variety of injuries. This will derive the demand for 3D cell culture system.
However, the scaffold-based segment holds the largest market share in the global market in the product segment. The use of hydrogels in the scaffold-based 3D cell culture is the key factor driving the scaffold-based segment, as they can be derived naturally from protein and ECM components.
Europe is expected to grow at the highest CAGR during the forecast period
This is because of the recent increase in investments for Research and Development and Healthcare sector. The biotech industry in Europe spends nearly USD 7.32 billion in R&D and USD23.2 billion in revenue. The average size of biotech in Europe had grown to USD165 million with CAGR of 20 % since 2012.
The Favorable policies made by the European Commission to improve the investment climate pertaining to the biotech industry. The increased investment will help to grow the pharmaceutical and biotechnology industry. Also the recent commercialization of microfluidics-based products, the increasing presence of major market players, and a large number of research activities conducted in the region. This will help the 3D cell culture system market to grow at the highest pace.
However, North America has dominated the 3D cell culture system market with the largest share of the market due to the increasing incidence of cancer and the presence of a well-established pharmaceutical & biotechnology industry
The Asia Pacific is expected to witness the fastest growth next to the Europe region over the forecast period due to developing infrastructure in this region, coupled with increasing awareness about upcoming technologies in health care amongst the population.
The key players in the industry have adopted agreement and partnership as the developmental strategies to strengthen their market foothold. For instance, Lonza Group Ltd. signed an agreement with TAP Biosystems to distribute the former’s RAFT 3D cell culture system, which helped Lonza to expand its presence in the global market.
Thermo Fisher Scientific (US) is the leading player in the 3D cell culture system market.The company invested USD967 million and USD887 million in R&D activities in 2019 and 2017 respectively in order to sustain its position in the market. It also adopted the growth strategies such as acquisitions and expansions, For instance, Thermo Fisher Scientific acquired the Advanced Bioprocessing business of BD (US) in October 2019, to enhance its presence in the 3D cell culture systems market.
Apart from this many companies are also entering into this segment due to the increase in demand for the 3D cell culture, Some of the major companies into 3D cell culture are Corning Incorporated (US), Hµrel Corporation (US), QGel SA (Switzerland), SynVivo (US), Advanced BioMatrix (US), Greiner Bio-One International (Austria), Merck KGaA (Germany),Lonza AG (Switzerland), REPROCELL Incorporated (Japan), TissUse (Germany), InSphero (Switzerland), Synthecon (US), 3D Biotek (US), CN Bio (UK), Hamilton Company (US),
3D cell culture system Key Market Segments:
3D cell culture system Key Market, By Product
- Scaffold-based 3D Cell Cultures
- Hydrogels/ECM Analogs
- Micropatterned Surfaces
- Scaffold-free 3D Cell Cultures
- Low Attachment Plates
- Microfluidics-based 3D Cell Cultures
- Magnetic & Bio-printed 3D Cell Cultures
3D cell culture system Key Market, By Application
- Tissue Engineering & Regenerative Medicine
- Cancer & Stem Cell Research
- Drug Discovery & Toxicology Testing
3D cell culture system Key Market, By End User
- Research Institutes
- Hospitals and diagnostics centers
- Pharmaceutical & Biotechnology Companies
- Cosmetics Industry
- Other End Users
3D cell culture system Key Market, By Region
- North America
- Asia Pacific
- Middle east and Africa
- Latin America